Compounds and compositions and uses thereof
AssigneesSunovion Pharmaceuticals Inc., PGI Drug Discovery LLC
InventorsVadim Alexandrov, Carrie A. Bowen, Taleen G. Hanania, Noel Aaron Powell
Life of this patent
Estimating the term…
Abstract
Compounds of formula I: are disclosed, as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric diseases and disorders in a subject in need thereof are also disclosed.
Claims45
A composition comprising a compound, wherein said compound is:
- or a pharmaceutically acceptable salt thereof, and wherein said composition is greater than 90% enantiomerically pure.
A composition comprising a compound, wherein said compound is:
- or a pharmaceutically acceptable salt thereof, and wherein said composition is greater than 90% enantiomerically pure.
A pharmaceutical composition comprising a compound, wherein said compound is:
- or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant, or vehicle.
A pharmaceutical composition comprising a compound, wherein said compound is:
- or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant, or vehicle.
A method for alleviating or inhibiting the progress of a neurological or psychiatric disease or disorder selected from the group consisting of depression, bipolar disorder, pain, schizophrenia, obsessive compulsive disorder, addiction, social disorder, attention deficit hyperactivity disorder, an anxiety disorder, a movement disorder, epilepsy, Alzheimer's disease, Parkinson's disease, autism and cognitive impairments in a subject in need thereof, comprising administering to said subject an effective amount of a compound, wherein said compound is:
- or a pharmaceutically acceptable salt thereof.
A method of alleviating or inhibiting the progress of a neurological or psychiatric disease or disorder selected from the group consisting of depression, bipolar disorder, pain, schizophrenia, obsessive compulsive disorder, addiction, social disorder, attention deficit hyperactivity disorder, an anxiety disorder, a movement disorder, epilepsy, Alzheimer's disease, Parkinson's disease, autism and cognitive impairments in a subject in need thereof, comprising administering to said subject an effective amount of a compound, wherein said compound is:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.